Swedish probiotics specialist BioGaia AB is in a unique position to capitalize on the global probiotics trend, which has been boosted by the coronavirus pandemic, according to the firm’s CEO Isabelle Ducellier.
Scientific Evidence And E-Commerce Key To Seizing The Probiotic Opportunity
Exclusive: CEO of global probiotic firm BioGaia, Isabelle Ducellier, speaks to HBW Insight about the company's science- and e-commerce- based growth strategy.
More from Strategy
• By
Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.
• By
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
• By
Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.
• By
Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.
More from Business
• By
Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
• By
Growing use of GLP-1 receptor agonists is having a positive knock-on effect on the dietary supplements market, reports OptiBiotix Health, marketer of the SlimBiome weight management prebiotic.